71
Views
3
CrossRef citations to date
0
Altmetric
Clinical Features

Management of Rheumatic Diseases During Pregnancy

, MD & , MD, MS
Pages 213-221 | Published online: 13 Mar 2015

References

  • . Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90–96
  • . Symons DP. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol. 2002;16(5):707–722
  • . Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006;54(3):899–907
  • . Katz PP. Childbearing decisions and family size among women with rheumatoid arthritis. Arthritis Rheum. 2006;55(2):217–223
  • . Golding A, Haque UJ, Giles JT. Rheumatoid arthritis and reproduction. Rheum Dis Clin North Am. 2007;33(2):319–343
  • . de Man Y, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241–1248
  • . Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 1999;42(6):1219–1227
  • . Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med. 1993;329(7):466–471
  • . Ostensen M, Lockshin M, Doria A, . Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford). 2008;47( suppl 3):iii28–iii31
  • . Skomsvoll JF, Ostensen M, Irgens LM, Baste V. Obstetrical and neonatal outcome in pregnant patients with rheumatic diseases. Scand J Rheumatol Suppl. 1998;107:109–112
  • . Bowden AP, Barrett JH, Fallow W, Silman AJ. Women with inflammatory polyarthritis have babies of lower birth weight. J Rheumatol. 2001;28(2):355–359
  • . Chambers CD, Johnson DL, Jones KL. Pregnancy outcome in women exposed to anti-TNF-alpha medications: The OTIS rheumatoid arthritis pregnancy study. Abstract 1224. Arthritis Rheum. 2004;50:S479
  • . de Man YA, Hazes JM, van der Heide H, . Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum. 2009;60(11):3196–3206
  • . Ostensen M. The influence of pregnancy on blood parameters in patients with rheumatic disease. Scand J Rheumatol. 1984;13(3):203–208
  • . Barrett JH, Brennan P, Fiddler M, Silman A. Breastfeeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum. 2000;43(5):1010–1015
  • . Aho K, Heliövaara M. Risk factors for rheumatoid arthritis. Ann Med. 2004;36(4):242–251
  • . Zoli A, Lizzio MM, Ferlisi EM, . ACTH, cortical and prolactin in active rheumatoid arthritis. Clin Rheumatol. 2002;21(4):289–293
  • . Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11(3):229
  • . Carbone LD, Cooper C, Michet CJEA. Ankylosing spondylitis in Rochester, Minnesota, 1935–1989. Is the epidemiology changing? Arthritis Rheum. 1992;35(12):1476–1482
  • . Ostensen M, Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 1983;26(9):1155–1159
  • . Ostensen M, Ostensen H. Ankylosing spondylitis–female aspect. J Rheumatol. 1998;25(1):120–124
  • . Ostensen M, Husby G. Ankylosing spondylitis and pregnancy. Rheum Dis Clin North Am. 1989;15(2):241–254
  • . Ostensen. The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol. 1992:28(3–4);235–223
  • . Ghozlani I, Ghazi M, Nouijai A. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009;44(5):772–776
  • . Geusens P, Vosse D, van der Linden S. Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol. 2007;19(4):335–339
  • . Cooper C, Carbone L, Michet CJ, Atkinson EJ, O'Fallon WM, Melton LJ 3rd. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol. 1994;21(10):1877–1882
  • . Jang JY, Lee JG, Jeong IK, . A case of post-pregnancy osteoporosis combined with ankylosing spondylitis. Rheumatol Int. 2009;29(11):1359–1362
  • . Allali A. case of post-pregnancy osteoporosis-related spinal fractures in association with ankylosing spondylitis. Clin Rheumatol. 2005;24(4):435–436
  • . Buhimschi CS, Buhimschi IA, Malinow AM, Weiner CP. Intrauterine pressure during the second stage of labor in obese women. Obstet Gynecol. 2004;103(5 pt 1):225–230
  • . Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34(3):J314–J321
  • . Horn EJ, Chambers CD, Menter A, Kimball AB; International Psoriasis Council.Pregnancy outcomes in psoriasis: why do we know so little? J Am Acad Dermatol. 2009;61(2):e5–e8
  • . Ostensen M. Pregnancy in psoriatic arthritis. Scand J Rheumatol. 1988;17(1):67–70
  • . Dunna SF, Finlay AY. Psoriasis: improvement during and worsening after pregnancy. Br J Dermatol. 1989;120(4):584
  • . Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol. 2005;141(5):601–606
  • . Swanbeck G, Inerot A, Martinsson T, . Genetic counseling in psoriasis: empirical data on psoriasis among first-degree relatives of 3095 psoriatic probands. Br J Dermatol. 1997;137(6):939–942
  • . Weatherhead S, Robson SC, Reynolds NJ. Management of psoriasis in pregnancy. BMJ. 2007;334(7605):1218–1220
  • . Tauscher AE, Fleischer AB Jr, Phelps KC, Feldman SR. Psoriasis and pregnancy. J Cutan Med Surg. 2002;6(6):561–570
  • . Lam J, Polifka JE, Dohil MA. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J Am Acad Dermatol. 2008;59(2):295–315
  • . Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007;56(6):2092–2096
  • . Turner SJ, Levine L, Redman A. Lupus erythematosus and pregnancy. Obstet Gynecol. 1956;8:601–609
  • . Vinet E, Pineau C, Gordon C, Clarke AE, Bernatsky S. Systemic lupus erythematosus in women: impact on family size. Arthritis Rheum. 2008;59(11):1656–1660
  • . Ekblom-Kullberg S, Kautiainen H, Helve AT, Leirisalo-Repo M, Julkunen H. Reproductive health in women with systemic lupus erythematosus compared to population controls. Scand J Rheumatol. 2009;38(5):375–380
  • . Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am. 2007;33(2):237–252
  • . Chakravarty EF, Colón I, Langen ES, . Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192(6):1897–1904
  • . Cortes-Hernandez J, Ordi-Ros J, Paredes F, . Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford). 2002;41(6):643–650
  • . Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52(2):514–521
  • . Tincani A, Bazzani C, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. Semin Thromb Hemost. 2008;34(3):267–273
  • . Lassere M, Empson M. Treatment of antiphospholipid syndrome in pregnancy—a systematic review of randomized therapeutic trials. Thromb Res. 2004;114(5–6):419–426
  • . Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am. 2007;33(2):267–285
  • . Llanos C, Izmirly PM, Katholi M, . Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum. 2009;60(10):3091–3097
  • . Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol. 2009;5(3):139–148
  • . Costedoat-Chalumeau N, Amoura Z, Duhaut P, . Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003;48(11):3207–3211
  • . Levy RA, Vilela VS, Cataldo MJ, . Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus. 2001;10(6):401–404
  • . Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol. 2009;33(3):196–205
  • . Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays. J Rheumatol. 2007;34(7):1514–1521

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.